Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

F Singer

Showing results (501-510 of 649) with videos related to

Pageof 65
Sort By:
Breast Cancer Research and Treatment|February 14, 2019
Oophorectomy and risk of contralateral breast cancer among BRCA1 and BRCA2 mutation carriersJoanne Kotsopoulos, Jan Lubinski, Henry T Lynch, et al.
International Journal of Epidemiology|March 17, 2018
Prospective evaluation of body size and breast cancer risk among BRCA1 and BRCA2 mutation carriersShana J Kim, Tomasz Huzarski, Jacek Gronwald, et al.
British Journal of Cancer|December 3, 2013
Incidence of colorectal cancer in BRCA1 and BRCA2 mutation carriers: results from a follow-up studyC M Phelan, J Iqbal, H T Lynch, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 17, 2018
<i>PIK3CA</i> Amplification Associates with Aggressive Phenotype but Not Markers of AKT-MTOR Signaling in Endometrial CarcinomaFrederik Holst, Henrica M J Werner, Siv Mjøs, et al.
Journal of the National Cancer Institute|June 27, 2024
Incidence of peritoneal cancer after oophorectomy among BRCA1 and BRCA2 mutation carriersSteven A Narod, Jacek Gronwald, Beth Karlan, et al.
British Journal of Cancer|November 29, 2023
Risk-reducing mastectomy and breast cancer mortality in women with a BRCA1 or BRCA2 pathogenic variant: an international analysisKelly Metcalfe, Tomasz Huzarski, Jacek Gronwald, et al.
Frontiers in Oncology|March 25, 2026
Correction: Part II: consensus statements and expert recommendations for BRCA-associated breast cancer in the Asia-Pacific region: clinical managementYeon Hee Park, Soo Chin Lee, Christian F Singer, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 25, 2012
Tamoxifen and anastrozole as a sequencing strategy: a randomized controlled trial in postmenopausal patients with endocrine-responsive early breast cancer from the Austrian Breast and Colorectal Cancer Study GroupPeter C Dubsky, Raimund Jakesz, Brigitte Mlineritsch, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|August 24, 2021
Weight Gain and the Risk of Ovarian Cancer in <i>BRCA1</i> and <i>BRCA2</i> Mutation CarriersShana J Kim, Jan Lubinski, Tomasz Huzarski, et al.
Frontiers in Oncology|July 8, 2025
Part II: consensus statements and expert recommendations for BRCA-associated breast cancer in the Asia-Pacific region: clinical managementYeon Hee Park, Soo Chin Lee, Christian F Singer, et al.
Pageof 65

Showing results (501-510 of 649) with videos related to

Sort By:
Pageof 65
Breast Cancer Research and Treatment|February 14, 2019
Oophorectomy and risk of contralateral breast cancer among BRCA1 and BRCA2 mutation carriersJoanne Kotsopoulos, Jan Lubinski, Henry T Lynch, et al.
International Journal of Epidemiology|March 17, 2018
Prospective evaluation of body size and breast cancer risk among BRCA1 and BRCA2 mutation carriersShana J Kim, Tomasz Huzarski, Jacek Gronwald, et al.
British Journal of Cancer|December 3, 2013
Incidence of colorectal cancer in BRCA1 and BRCA2 mutation carriers: results from a follow-up studyC M Phelan, J Iqbal, H T Lynch, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 17, 2018
<i>PIK3CA</i> Amplification Associates with Aggressive Phenotype but Not Markers of AKT-MTOR Signaling in Endometrial CarcinomaFrederik Holst, Henrica M J Werner, Siv Mjøs, et al.
Journal of the National Cancer Institute|June 27, 2024
Incidence of peritoneal cancer after oophorectomy among BRCA1 and BRCA2 mutation carriersSteven A Narod, Jacek Gronwald, Beth Karlan, et al.
British Journal of Cancer|November 29, 2023
Risk-reducing mastectomy and breast cancer mortality in women with a BRCA1 or BRCA2 pathogenic variant: an international analysisKelly Metcalfe, Tomasz Huzarski, Jacek Gronwald, et al.
Frontiers in Oncology|March 25, 2026
Correction: Part II: consensus statements and expert recommendations for BRCA-associated breast cancer in the Asia-Pacific region: clinical managementYeon Hee Park, Soo Chin Lee, Christian F Singer, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 25, 2012
Tamoxifen and anastrozole as a sequencing strategy: a randomized controlled trial in postmenopausal patients with endocrine-responsive early breast cancer from the Austrian Breast and Colorectal Cancer Study GroupPeter C Dubsky, Raimund Jakesz, Brigitte Mlineritsch, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|August 24, 2021
Weight Gain and the Risk of Ovarian Cancer in <i>BRCA1</i> and <i>BRCA2</i> Mutation CarriersShana J Kim, Jan Lubinski, Tomasz Huzarski, et al.
Frontiers in Oncology|July 8, 2025
Part II: consensus statements and expert recommendations for BRCA-associated breast cancer in the Asia-Pacific region: clinical managementYeon Hee Park, Soo Chin Lee, Christian F Singer, et al.
Pageof 65